Rayonier Advanced Materials Inc. has 4 Schedule 13D or 13G filings on record since 2026-02-25. 1 holder's latest filing reports 5% or more of common stock, par value $0.01 per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| AIPCF VIII (Cayman), Ltd. | 5.04% | 3,400,000 | SCHEDULE 13D/A, 2026-07-15 | 2026-07-14 |
| Dimensional Fund Advisors LP | 4.9% | 3,298,912 | SCHEDULE 13G/A, 2026-07-14 | 2026-06-30 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-27 | 2026-03-13 |
Purpose of Transaction (Item 4)
AIPCF VIII (Cayman), Ltd.
Item 4 of the Initial Statement is hereby amended and restated as follows: On April 20, 2026, the Issuer announced that it is engaged in a formal process to explore strategic alternatives to maximize shareholder value. In connection therewith, the Reporting Persons entered into a standard confidentiality agreement with the Issuer, which includes customary "standstill" and other customary non-disclosure and non-use provisions. In this regard, if the Reporting Persons (or any of their affiliates) are invited to further participate in the strategic review process by the Issuer or the Board of Directors of the Issuer (the "Board") (or any committee thereof) or any of their respective representatives or advisors, the Reporting Persons expect that they (or one or more of their affiliates) are likely to do some or all of the following depending on how the process were to develop: -conduct due diligence on the Issuer and its subsidiaries; -subject to further due diligence and applicable internal approvals, submit one or more non-binding proposals (any such proposal, a "Proposal") to the Board (or any committee thereof) with respect to the acquisition of some or all of the Issuer's assets or shares or other transaction involving the Issuer, on terms and conditions to be set forth in any such proposal (any such transaction, a "Proposed Transaction"); -enter into discussions and negotiations with the Issuer and/or the Board (or any committee thereof), management of the Issuer and …The first part of Item 4 of the SCHEDULE 13D/A filed 2026-07-15; the filing has the rest
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2026-02-25 | AIPCF VIII (Cayman), Ltd. | 5.07% | SCHEDULE 13D |
| 2026-03-27 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-07-14 | Dimensional Fund Advisors LP | 4.9% | SCHEDULE 13G/A |
| 2026-07-15 | AIPCF VIII (Cayman), Ltd. | 5.04% | SCHEDULE 13D/A |
Tools for this story
Each opens in a new tab, filled in for Rayonier Advanced Materials Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.